Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71.8M Sell
700,429
-120,977
-15% -$12.3M 2.39% 12
2025
Q4
$82.6M Sell
821,406
-191,576
-19% -$18.9M 2.64% 8
2025
Q3
$87.6M Sell
1,012,982
-162,894
-14% -$12.9M 2.6% 9
2025
Q2
$89.7M Buy
1,175,876
+334,931
+40% +$24.5M 3.07% 12
2025
Q1
$59.6M Buy
840,945
+599,710
+249% +$46.9M 2.1% 18
2024
Q4
$18.9M Buy
+241,235
New +$22.5M 0.56% 51

Other funds holding NUVL

Braidwell's NUVL Position: Q1 2026 in Review

Braidwell reduced its Nuvalent (NUVL) stake by 15% in Q1 2026, selling an estimated $12.3M and leaving 700,429 shares worth $71.8M. The position accounts for 2.39% of the portfolio, ranked #12.

Braidwell first reported a position in NUVL in Q4 2024 and has held it in 6 quarters since. The position peaked at $89.7M in Q2 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Braidwell held 700,429 shares of Nuvalent worth $71.8M as of Q1 2026.
  • Braidwell sold 120,977 Nuvalent shares in Q1 2026, an estimated $12.3M.
  • Nuvalent made up 2.39% of Braidwell's portfolio in Q1 2026, its #12 holding.
  • Braidwell first reported a position in Nuvalent in Q4 2024 and has held it in 6 quarters since.
  • Braidwell's Nuvalent position peaked at $89.7M in Q2 2025.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Braidwell's 13F filing for Q1 2026, filed 15 May 2026.